Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: Q4Q840
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 1 |
GO:0016787 | hydrolase activity | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 66 | 70 | PF00656 | 0.528 |
CLV_PCSK_SKI1_1 | 287 | 291 | PF00082 | 0.554 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.521 |
DEG_SPOP_SBC_1 | 26 | 30 | PF00917 | 0.492 |
DEG_SPOP_SBC_1 | 91 | 95 | PF00917 | 0.528 |
DOC_CDC14_PxL_1 | 138 | 146 | PF14671 | 0.551 |
DOC_CKS1_1 | 265 | 270 | PF01111 | 0.435 |
DOC_CYCLIN_yCln2_LP_2 | 178 | 184 | PF00134 | 0.572 |
DOC_MAPK_gen_1 | 165 | 172 | PF00069 | 0.491 |
DOC_MAPK_MEF2A_6 | 204 | 212 | PF00069 | 0.473 |
DOC_PP2B_LxvP_1 | 178 | 181 | PF13499 | 0.557 |
DOC_USP7_MATH_1 | 112 | 116 | PF00917 | 0.593 |
DOC_USP7_MATH_1 | 118 | 122 | PF00917 | 0.750 |
DOC_USP7_MATH_1 | 137 | 141 | PF00917 | 0.472 |
DOC_USP7_MATH_1 | 185 | 189 | PF00917 | 0.616 |
DOC_USP7_MATH_1 | 26 | 30 | PF00917 | 0.586 |
DOC_USP7_MATH_1 | 92 | 96 | PF00917 | 0.634 |
DOC_WW_Pin1_4 | 128 | 133 | PF00397 | 0.769 |
DOC_WW_Pin1_4 | 180 | 185 | PF00397 | 0.631 |
DOC_WW_Pin1_4 | 264 | 269 | PF00397 | 0.455 |
LIG_14-3-3_CanoR_1 | 156 | 164 | PF00244 | 0.306 |
LIG_APCC_ABBA_1 | 208 | 213 | PF00400 | 0.341 |
LIG_BIR_III_2 | 129 | 133 | PF00653 | 0.619 |
LIG_BRCT_BRCA1_1 | 54 | 58 | PF00533 | 0.418 |
LIG_FHA_1 | 158 | 164 | PF00498 | 0.560 |
LIG_FHA_1 | 288 | 294 | PF00498 | 0.522 |
LIG_FHA_1 | 46 | 52 | PF00498 | 0.396 |
LIG_FHA_2 | 122 | 128 | PF00498 | 0.744 |
LIG_FHA_2 | 187 | 193 | PF00498 | 0.607 |
LIG_FHA_2 | 36 | 42 | PF00498 | 0.558 |
LIG_FHA_2 | 64 | 70 | PF00498 | 0.522 |
LIG_Integrin_RGD_1 | 67 | 69 | PF01839 | 0.510 |
LIG_LIR_Gen_1 | 55 | 65 | PF02991 | 0.416 |
LIG_LIR_Nem_3 | 238 | 242 | PF02991 | 0.463 |
LIG_LIR_Nem_3 | 267 | 272 | PF02991 | 0.468 |
LIG_LIR_Nem_3 | 55 | 61 | PF02991 | 0.415 |
LIG_Pex14_1 | 14 | 18 | PF04695 | 0.510 |
LIG_Pex14_2 | 254 | 258 | PF04695 | 0.364 |
LIG_REV1ctd_RIR_1 | 268 | 277 | PF16727 | 0.485 |
LIG_SH2_CRK | 265 | 269 | PF00017 | 0.435 |
LIG_SH2_NCK_1 | 138 | 142 | PF00017 | 0.609 |
LIG_SH2_NCK_1 | 242 | 246 | PF00017 | 0.367 |
LIG_SH2_STAP1 | 231 | 235 | PF00017 | 0.391 |
LIG_SH2_STAT5 | 162 | 165 | PF00017 | 0.432 |
LIG_SH2_STAT5 | 269 | 272 | PF00017 | 0.421 |
LIG_SH3_3 | 129 | 135 | PF00018 | 0.741 |
LIG_SH3_3 | 171 | 177 | PF00018 | 0.596 |
LIG_SH3_3 | 178 | 184 | PF00018 | 0.586 |
LIG_SH3_3 | 20 | 26 | PF00018 | 0.475 |
LIG_SH3_3 | 59 | 65 | PF00018 | 0.386 |
LIG_SUMO_SIM_anti_2 | 215 | 220 | PF11976 | 0.351 |
LIG_SUMO_SIM_anti_2 | 50 | 55 | PF11976 | 0.383 |
LIG_SUMO_SIM_par_1 | 32 | 38 | PF11976 | 0.371 |
LIG_SUMO_SIM_par_1 | 48 | 55 | PF11976 | 0.403 |
LIG_TRAF2_1 | 282 | 285 | PF00917 | 0.545 |
LIG_WW_1 | 135 | 138 | PF00397 | 0.638 |
MOD_CK1_1 | 121 | 127 | PF00069 | 0.705 |
MOD_CK1_1 | 158 | 164 | PF00069 | 0.473 |
MOD_CK1_1 | 240 | 246 | PF00069 | 0.374 |
MOD_CK1_1 | 93 | 99 | PF00069 | 0.565 |
MOD_CK2_1 | 121 | 127 | PF00069 | 0.722 |
MOD_CK2_1 | 180 | 186 | PF00069 | 0.609 |
MOD_GlcNHglycan | 114 | 117 | PF01048 | 0.520 |
MOD_GlcNHglycan | 118 | 121 | PF01048 | 0.553 |
MOD_GlcNHglycan | 139 | 142 | PF01048 | 0.681 |
MOD_GlcNHglycan | 189 | 192 | PF01048 | 0.526 |
MOD_GlcNHglycan | 196 | 199 | PF01048 | 0.565 |
MOD_GlcNHglycan | 255 | 258 | PF01048 | 0.300 |
MOD_GlcNHglycan | 29 | 32 | PF01048 | 0.672 |
MOD_GlcNHglycan | 71 | 76 | PF01048 | 0.456 |
MOD_GlcNHglycan | 96 | 99 | PF01048 | 0.635 |
MOD_GSK3_1 | 112 | 119 | PF00069 | 0.674 |
MOD_GSK3_1 | 86 | 93 | PF00069 | 0.524 |
MOD_N-GLC_1 | 156 | 161 | PF02516 | 0.417 |
MOD_NEK2_1 | 52 | 57 | PF00069 | 0.440 |
MOD_PKA_2 | 155 | 161 | PF00069 | 0.452 |
MOD_PKA_2 | 86 | 92 | PF00069 | 0.570 |
MOD_Plk_1 | 237 | 243 | PF00069 | 0.480 |
MOD_Plk_4 | 158 | 164 | PF00069 | 0.510 |
MOD_Plk_4 | 47 | 53 | PF00069 | 0.398 |
MOD_ProDKin_1 | 128 | 134 | PF00069 | 0.769 |
MOD_ProDKin_1 | 180 | 186 | PF00069 | 0.633 |
MOD_ProDKin_1 | 264 | 270 | PF00069 | 0.455 |
MOD_SUMO_rev_2 | 168 | 177 | PF00179 | 0.594 |
TRG_DiLeu_BaLyEn_6 | 140 | 145 | PF01217 | 0.535 |
TRG_ER_diArg_1 | 227 | 230 | PF00400 | 0.494 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I496 | Leptomonas seymouri | 47% | 93% |
A0A1X0NQQ5 | Trypanosomatidae | 32% | 96% |
A0A3Q8IER6 | Leishmania donovani | 93% | 100% |
A0A422N9C9 | Trypanosoma rangeli | 37% | 96% |
A4HGS8 | Leishmania braziliensis | 80% | 100% |
A4I3V5 | Leishmania infantum | 93% | 100% |
D0A923 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 100% |
E9B045 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
V5D5P4 | Trypanosoma cruzi | 40% | 99% |